Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)

Concept paper on the revision of the guideline on pharmaceutical fixed combination products (EMA/CVMP/83804/2005-Rev.1)

Guideline on data requirements to support in-use stability claims for veterinary vaccines - Revision 1

Summary of opinion: Trodelvy, 23/07/2026 Positive

Withdrawn application: Dupixent, 24/06/2026

Human medicines European public assessment report (EPAR): Kigabeq, vigabatrin, Date of authorisation: 20/09/2018, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Lumykras, sotorasib, Date of authorisation: 06/01/2022, Revision: 8, Status: Authorised

Lumykras : EPAR - Risk management plan

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Opzelura, ruxolitinib, Date of authorisation: 19/04/2023, Revision: 7, Status: Authorised